Back to top
more

AMN Healthcare Services (AMN)

(Delayed Data from NYSE)

$17.24 USD

17.24
2,127,266

+0.32 (1.89%)

Updated Aug 8, 2025 04:00 PM ET

After-Market: $17.25 +0.01 (0.06%) 7:02 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (97 out of 244)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Reasons to Retain Ecolab (ECL) Stock in Your Portfolio For Now

by Zacks Equity Research

Investors continue to be optimistic about Ecolab (ECL) owing to its solid product portfolio.

Zacks Equity Research

Here's Why You Should Hold on to Inogen (INGN) Stock Now

by Zacks Equity Research

Inogen (INGN) continues to benefit from strength in the direct-to-customer business model. However, rising costs remain a woe.

Zacks Equity Research

Here's Why You Should Hold on to Align Technology (ALGN) Now

by Zacks Equity Research

Investors are optimistic about Align Technology (ALGN) on the growing market adoption of the iTero Element 5D Plus imaging system.

Zacks Equity Research

Here's Why You Should Hold on to NuVasive (NUVA) Stock for Now

by Zacks Equity Research

Investors are optimistic about NuVasive's (NUVA) better-than-expected revenues and strong spine market presence.

Tirthankar Chakraborty headshot

3 Top Momentum Stocks to Buy Using Driehaus Strategy

by Tirthankar Chakraborty

Stocks like Builders FirstSource (BLDR), AMN Healthcare Services (AMN) and PDC Energy (PDCE) have been selected as the momentum picks for the day using the Driehaus strategy.

Zacks Equity Research

Reasons to Retain OPKO Health (OPK) Stock in Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about OPKO Health (OPK) owing to its potential in Rayaldee and regulatory approvals.

Zacks Equity Research

Henry Schein (HSIC) Digital Dentistry Gains, Expands Globally

by Zacks Equity Research

Henry Schein (HSIC) witnesses strength in dental consumable merchandise sales in France, Germany, Austria, Belgium.

Zacks Equity Research

Masimo (MASI) Announces Favorable Study Results on SpHb

by Zacks Equity Research

Masimo's (MASI) SpHb is likely to enhance perioperative transfusion management and post-operative patient outcomes on pediatric patients.

Zacks Equity Research

Alcon (ALC) Publishes Dividend, New Board Member Addition Plans

by Zacks Equity Research

Alcon's 2022 AGM is set to take place in a closed format without the personal presence of shareholders.

Zacks Equity Research

Here's Why You Should Hold on to DexCom (DXCM) Stock Now

by Zacks Equity Research

DexCom (DXCM) continues to benefit from a solid product portfolio and a strong international presence. However, supply constraints remain a woe.

Zacks Equity Research

Here's Why You Should Invest in IDEXX (IDXX) Stock for Now

by Zacks Equity Research

Investors are optimistic about IDEXX's (IDXX) strong international performances and favorable 2022 outlook.

Zacks Equity Research

Abbott's (ABT) CGM Device Gets MHLW Nod for Expanded Coverage

by Zacks Equity Research

Abbott's (ABT) FreeStyle Libre system will allow diabetics to get the glucose data required to manage their condition without using routine fingersticks.

Zacks Equity Research

Medtronic (MDT) Completes 1st Patient Implant of Implantable TNM

by Zacks Equity Research

Medtronic's (MDT) TITAN 2 study will examine the safety and efficacy of the implantable TNM device in people with OAB.

Zacks Equity Research

Here's Why You Should Retain QIAGEN (QGEN) Stock for Now

by Zacks Equity Research

Investors are optimistic about QIAGEN's (QGEN) recent expansion in test menu and strategic collaborations.

Zacks Equity Research

Zacks.com featured highlights include AMN Healthcare Services, Hawkins and Arthur J. Gallagher

by Zacks Equity Research

AMN Healthcare Services, Hawkins and Arthur J. Gallagher have been highlighted in this Screen of the Week article.

Zacks Equity Research

Neogen's (NEOG) Q3 Earnings Miss Estimates, Margins Down

by Zacks Equity Research

Robust segmental performance and contributions from the Soleris product line drive the top line for Neogen (NEOG) in third-quarter of fiscal 2022 results.

Zacks Equity Research

Reasons to Retain Intuitive Surgical (ISRG) Stock For Now

by Zacks Equity Research

Investors continue to be optimistic about Intuitive Surgical (ISRG) owing to its strength in robotics.

Tirthankar Chakraborty headshot

3 Top Stocks to Invest In for Solid Earnings Growth

by Tirthankar Chakraborty

Invest in stocks like AMN Healthcare Services (AMN), Hawkins (HWKN) & Arthur J. Gallagher (AJG) at the moment for super earnings growth.

Zacks Equity Research

AMN Healthcare Services (AMN) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, AMN Healthcare Services (AMN) closed at $103.47, marking a -1% move from the previous day.

Zacks Equity Research

Here's Why You Should Retain BD (BDX) Stock in Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about BD (BDX) owing to its slew of product launches and strategic deals.

Zacks Equity Research

Here's Why You Should Hold on to Thermo Fisher (TMO) Stock Now

by Zacks Equity Research

Investors are optimistic about Thermo Fisher (TMO) on its progress with COVID-19-related products and services.

Zacks Equity Research

QIAGEN (QGEN) QuantiFeron Hits New Sales Landmark in TB Testing

by Zacks Equity Research

According to QIAGEN (QGEN), QuantiFERON is different from other IGRA tests based on its efficient workflow.

Zacks Equity Research

HealthEquity (HQY) Q4 Earnings Lag Estimates, Margins Down

by Zacks Equity Research

HealthEquity (HQY) witnesses solid growth in HSAs, along with recording robust Custodial and Interchange revenues, in the fourth quarter of fiscal 2022.

Zacks Equity Research

Here's Why You Should Invest in Patterson Companies (PDCO) Stock

by Zacks Equity Research

Patterson Companies (PDCO) continues to benefit from strength in the Animal Health business and dental business.

Zacks Equity Research

Philips (PHG) Ties Up With Nuvo Group to Boost Maternal Care

by Zacks Equity Research

Philips (PHG) collaborates with Nuvo to develop maternity care services with digital solutions and eco-system building in rural areas